Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis

Low muscle mass has been associated with worse clinical outcomes in various cancers. This work investigated whether, during tyrosine kinases inhibitors (TKIs) therapy, low muscle mass was associated with treatment toxicity and survival outcomes. A systematic literature search was performed in Pubmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinninella, Emanuele, Cintoni, Marco, Raoul, Pauline, Ponziani, Francesca Romana, Pompili, Maurizio, Pozzo, Carmelo, Strippoli, Antonia, Bria, Emilio, Tortora, Giampaolo, Gasbarrini, Antonio, Mele, Maria Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
CE-Systematic reviews and meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310498/
https://www.ncbi.nlm.nih.gov/pubmed/33337518
http://dx.doi.org/10.1007/s11739-020-02589-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310498/
https://www.ncbi.nlm.nih.gov/pubmed/33337518
http://dx.doi.org/10.1007/s11739-020-02589-5

Ejemplares similares